BCL2 and acute myeloid leukemia: The activation of the integrated stress response (ISR) was shown to be sufficient for re-sensitizing venetoclax-resistant AML cells to Bcl-2 inhibition, hence promoting apoptosis when administered in combination with venetoclax treatment in vitro and in vivo [26].